WARRANT AND OPTION AGREEMENTWarrant and Option Agreement • January 22nd, 2019 • Lexaria Bioscience Corp. • Metal mining • Virginia
This Warrant and Option Agreement (“Agreement”) is executed as of January 15, 2019, by Lexaria Nicotine LLC, a Delaware limited liability company (the “Company”) and Lexaria Bioscience Corp., a Nevada corporation (“Company Holdings”), in favor of Altria Ventures Inc., a Virginia corporation (the “Initial Holder”), in accordance with the terms and subject to the conditions set forth in this Agreement. The Company, Company Holdings and the Initial Holder are each referred to herein as a “Party” and collectively as the “Parties.”
On ____________, 2008, you entered into an agreement with Pluristem Therapeutics Inc. (the “Company”) pursuant to which you were issued a warrant to purchase up to an _____________ shares of Common Stock with an exercise price of $1.00 per share...Warrant and Option Agreement • February 13th, 2009 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This is to confirm that you have agreed that the Warrant and the Option will not be exercisable until May _, 2009. It is agreed that in the event that the Company’s announcement that it is initiating its first human clinical trials comes before May _, 2009, then the Notice Period will commence on May _, 2009.
